Solid Biosciences Inc.

IPO

Home - Solid Biosciences

Solid Biosciences Inc. was founded in 2013, is headquartered in Charlestown, United States, lists 51–200 employees, and has $150.0M in recorded funding across 3 rounds.

Employees
51–200
Founded
2013
Business Model
B2B
Total Funding
$150.0M
Last Round
$50.0M Series CMar 2017
Rounds
3
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 6 investors for this company. The full record is or through the API.

About

Solid Biosciences is a precision genetic medicine company focused on advancing a portfolio of gene therapy candidates targeting rare neuromuscular and cardiac diseases, including Duchenne muscular dystrophy. Founded in 2013 after co-founder Ilan Ganot's son was diagnosed with DMD, the company develops AAV-based micro-dystrophin gene therapies and genetic regulator technologies. Its lead program SGT-003 is in active Phase I/II clinical trials.

Summary

Solid Biosciences Inc. is a Biotech company based in Charlestown, United States, founded in 2013. It lists 51–200 employees. It has raised $150.0M in total across 3 rounds, most recently a $50.0M Series C round in Mar 2017. Investors include RA Capital Management, Bain Capital Life Sciences and Deerfield Management.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

IPOJan 2018
$130.0M

Sign up to see all 4 events

Funding: Series A through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Solid Biosciences Inc. on Indexed.vc
<a href="https://indexed.vc/companies/solid-biosciences-inc"><img src="https://indexed.vc/api/badge/company/solid-biosciences-inc" alt="Solid Biosciences Inc. on Indexed.vc" width="260" height="76" /></a>